Revvity Pre-Tax Income 2010-2025 | RVTY
Revvity annual/quarterly pre-tax income history and growth rate from 2010 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Revvity pre-tax income for the quarter ending March 31, 2025 was $0.052B, a 51.62% increase year-over-year.
- Revvity pre-tax income for the twelve months ending March 31, 2025 was $0.334B, a 77.56% increase year-over-year.
- Revvity annual pre-tax income for 2024 was $0.316B, a 72.77% increase from 2023.
- Revvity annual pre-tax income for 2023 was $0.183B, a 71.93% decline from 2022.
- Revvity annual pre-tax income for 2022 was $0.652B, a 45.84% decline from 2021.
| Revvity Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $316 |
| 2023 | $183 |
| 2022 | $652 |
| 2021 | $1,204 |
| 2020 | $800 |
| 2019 | $237 |
| 2018 | $258 |
| 2017 | $297 |
| 2016 | $244 |
| 2015 | $209 |
| 2014 | $124 |
| 2013 | $164 |
| 2012 | $55 |
| 2011 | $64 |
| 2010 | $166 |
| 2009 | $100 |
| Revvity Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $52 |
| 2024-12-31 | $95 |
| 2024-09-30 | $100 |
| 2024-06-30 | $87 |
| 2024-03-31 | $35 |
| 2023-12-31 | $31 |
| 2023-09-30 | $51 |
| 2023-06-30 | $72 |
| 2023-03-31 | $29 |
| 2022-12-31 | $138 |
| 2022-09-30 | $82 |
| 2022-06-30 | $206 |
| 2022-03-31 | $225 |
| 2021-12-31 | $262 |
| 2021-09-30 | $135 |
| 2021-06-30 | $326 |
| 2021-03-31 | $480 |
| 2020-12-31 | $367 |
| 2020-09-30 | $234 |
| 2020-06-30 | $165 |
| 2020-03-31 | $35 |
| 2019-12-31 | $65 |
| 2019-09-30 | $63 |
| 2019-06-30 | $72 |
| 2019-03-31 | $37 |
| 2018-12-31 | $79 |
| 2018-09-30 | $78 |
| 2018-06-30 | $72 |
| 2018-03-31 | $29 |
| 2017-12-31 | $81 |
| 2017-09-30 | $105 |
| 2017-06-30 | $71 |
| 2017-03-31 | $40 |
| 2016-12-31 | $69 |
| 2016-09-30 | $65 |
| 2016-06-30 | $61 |
| 2016-03-31 | $49 |
| 2015-12-31 | $40 |
| 2015-09-30 | $64 |
| 2015-06-30 | $57 |
| 2015-03-31 | $48 |
| 2014-12-31 | $-25 |
| 2014-09-30 | $48 |
| 2014-06-30 | $61 |
| 2014-03-31 | $40 |
| 2013-12-31 | $67 |
| 2013-09-30 | $46 |
| 2013-06-30 | $27 |
| 2013-03-31 | $24 |
| 2012-12-31 | $-38 |
| 2012-09-30 | $31 |
| 2012-06-30 | $38 |
| 2012-03-31 | $24 |
| 2011-12-31 | $-39 |
| 2011-09-30 | $32 |
| 2011-06-30 | $35 |
| 2011-03-31 | $36 |
| 2010-12-31 | $49 |
| 2010-09-30 | $35 |
| 2010-06-30 | $55 |
| 2010-03-31 | $27 |
| 2009-12-31 | $28 |
| 2009-09-30 | $17 |
| 2009-06-30 | $34 |
| 2009-03-31 | $20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.153B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.273B | 26.50 |
| Elevance Health (ELV) | United States | $94.057B | 12.14 |
| CVS Health (CVS) | United States | $84.883B | 10.55 |
| Cencora (COR) | United States | $56.618B | 20.55 |
| Natera (NTRA) | United States | $21.276B | 0.00 |
| DiDi Global (DIDIY) | China | $19.908B | 30.21 |
| BioMerieux (BMXMF) | France | $15.658B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.897B | 0.00 |
| Solventum (SOLV) | United States | $11.572B | 10.79 |
| ICON (ICLR) | Ireland | $11.550B | 10.74 |
| CochLear (CHEOY) | Australia | $11.542B | 0.00 |
| Doximity (DOCS) | United States | $11.088B | 57.66 |
| Viatris (VTRS) | United States | $10.187B | 3.24 |
| Medpace Holdings (MEDP) | United States | $8.637B | 22.94 |
| Avantor (AVTR) | United States | $8.606B | 12.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.908B | 38.90 |
| Charles River Laboratories (CRL) | United States | $5.866B | 11.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.018B | 23.69 |
| BrightSpring Health Services (BTSG) | United States | $3.685B | 34.11 |
| Sotera Health (SHC) | United States | $3.667B | 20.84 |
| Alignment Healthcare (ALHC) | United States | $3.063B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.009B | 34.51 |
| Concentras Parent (CON) | United States | $2.767B | 14.39 |
| Organon (OGN) | United States | $2.267B | 2.41 |
| Progyny (PGNY) | United States | $2.005B | 44.15 |
| Ardent Health Partners (ARDT) | United States | $1.880B | 0.00 |
| Premier (PINC) | United States | $1.873B | 11.99 |
| GeneDx Holdings (WGS) | United States | $1.857B | 72.70 |
| GoodRx Holdings (GDRX) | United States | $1.799B | 39.08 |
| Agilon Health (AGL) | United States | $1.702B | 0.00 |
| PACS (PACS) | United States | $1.536B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.254B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.111B | 9.32 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.967B | 0.00 | |
| CareDx (CDNA) | United States | $0.845B | 13.19 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 6.01 |
| Embecta (EMBC) | United States | $0.724B | 4.96 |
| Nutex Health (NUTX) | United States | $0.720B | 14.10 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 13.67 |
| Sonida Senior Living (SNDA) | United States | $0.447B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 37.95 |
| InnovAge Holding (INNV) | United States | $0.391B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.375B | 0.00 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| SBC Medicals (SBC) | United States | $0.320B | 0.00 |
| DocGo (DCGO) | United States | $0.240B | 9.79 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.186B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.078B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| ModivCare (MODV) | United States | $0.020B | 7.05 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |